Catalent Pharma Solutions has provided integrated development, manufacturing, and delivery solutions for medicines and therapies since 1933. The company partners with pharmaceutical, biotech, and consumer health organisations to accelerate product development and manufacturing, operating more than 40 global sites staffed by thousands of scientists and technicians.
The company's technical capabilities span oral dose development and manufacturing, biologics development and manufacturing, specialty and clinical supply services, and advanced delivery technologies. Catalent delivers over 60 billion annual treatment doses to more than 200 million patients worldwide, positioning itself as a substantial player in the pharmaceutical supply chain.
Operations are characterised by a commitment to reliability and scalability in delivering therapies. Catalent works closely with partners through the development, manufacturing, and delivery phases, with particular emphasis on the integration of these stages to improve efficiency and reduce time to market.
